| Product Code: ETC9395898 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa mRNA Flu Vaccine Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa mRNA Flu Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa mRNA Flu Vaccine Market - Industry Life Cycle |
3.4 South Africa mRNA Flu Vaccine Market - Porter's Five Forces |
3.5 South Africa mRNA Flu Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Africa mRNA Flu Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 South Africa mRNA Flu Vaccine Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 South Africa mRNA Flu Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of mRNA flu vaccines in South Africa |
4.2.2 Rising prevalence of flu cases in the region |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in certain areas of South Africa |
4.3.2 High cost associated with mRNA flu vaccines |
4.3.3 Vaccine hesitancy among the population |
5 South Africa mRNA Flu Vaccine Market Trends |
6 South Africa mRNA Flu Vaccine Market, By Types |
6.1 South Africa mRNA Flu Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Africa mRNA Flu Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Africa mRNA Flu Vaccine Market Revenues & Volume, By Non-replicating mRNA, 2021- 2031F |
6.1.4 South Africa mRNA Flu Vaccine Market Revenues & Volume, By In Vivo Self-Replicating mRNA, 2021- 2031F |
6.1.5 South Africa mRNA Flu Vaccine Market Revenues & Volume, By In Vitro Dendritic Cell Non-Replicating mRNA Vaccine, 2021- 2031F |
6.2 South Africa mRNA Flu Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 South Africa mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1010, 2021- 2031F |
6.2.3 South Africa mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1020, 2021- 2031F |
6.2.4 South Africa mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1030, 2021- 2031F |
6.3 South Africa mRNA Flu Vaccine Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 South Africa mRNA Flu Vaccine Market Revenues & Volume, By Clinic, 2021- 2031F |
6.3.3 South Africa mRNA Flu Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 South Africa mRNA Flu Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 South Africa mRNA Flu Vaccine Market Import-Export Trade Statistics |
7.1 South Africa mRNA Flu Vaccine Market Export to Major Countries |
7.2 South Africa mRNA Flu Vaccine Market Imports from Major Countries |
8 South Africa mRNA Flu Vaccine Market Key Performance Indicators |
8.1 Percentage increase in flu vaccine coverage rate in South Africa |
8.2 Number of vaccination campaigns or programs conducted by the government |
8.3 Rate of adoption of mRNA flu vaccines compared to traditional flu vaccines |
9 South Africa mRNA Flu Vaccine Market - Opportunity Assessment |
9.1 South Africa mRNA Flu Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Africa mRNA Flu Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 South Africa mRNA Flu Vaccine Market Opportunity Assessment, By End use, 2021 & 2031F |
10 South Africa mRNA Flu Vaccine Market - Competitive Landscape |
10.1 South Africa mRNA Flu Vaccine Market Revenue Share, By Companies, 2024 |
10.2 South Africa mRNA Flu Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here